216014-15-2

Basic information

• Product Name: N-[3(R)-(Decanoyloxy)tetradecanoyl]-O3-[2-[3(R)-(decanoyloxy)tetradecanamido]-3-O-[3(R)-(decanoyloxy)tetradecanoyl]-2-deoxy-4-O-phosphono-beta-D-glucopyranosyl]-L-serine triethylammonium salt
• CAS NO: 216014-15-2
• Molecular Formula: C₈₇H₁₆₈N₃O₂₀P
• Molecular Weight: 1607.29091
• Mol File: 216014-15-2.mol

Chemical Properties

• CAS DataBase Reference: N-[3(R)-(Decanoyloxy)tetradecanoyl]-O3-[2-[3(R)-(decanoyloxy)tetradecanamido]-3-O-[3(R)-(decanoyloxy)tetradecanoyl]-2-deoxy-4-O-phosphono-beta-D-glucopyranosyl]-L-serine triethylammonium salt(CAS DataBase Reference)
• NIST Chemistry Reference: N-[3(R)-(Decanoyloxy)tetradecanoyl]-O3-[2-[3(R)-(decanoyloxy)tetradecanamido]-3-O-[3(R)-(decanoyloxy)tetradecanoyl]-2-deoxy-4-O-phosphono-beta-D-glucopyranosyl]-L-serine triethylammonium salt(216014-15-2)
• EPA Substance Registry System: N-[3(R)-(Decanoyloxy)tetradecanoyl]-O3-[2-[3(R)-(decanoyloxy)tetradecanamido]-3-O-[3(R)-(decanoyloxy)tetradecanoyl]-2-deoxy-4-O-phosphono-beta-D-glucopyranosyl]-L-serine triethylammonium salt(216014-15-2)

Safety Data

• Hazardous Substances Data: 216014-15-2(Hazardous Substances Data)

Upstream product

• 216014-19-6 N-[(R)-3-decanoyloxytetradecanoyl]-O-[2-deoxy-4-O-diphenylphosphono-2-[(R)-3-decanoyloxytetradecanoylamino]-3-O-[(R)-3-decanoyloxytetradecanoyl]-β-D-glucopyranosyl]-L-serine benzyl ester 

Relevant articles and documents

Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor

This invention relates to processes for production of alkylamino glucosaminide phosphate compounds, and of disaccharide compounds, including various novel intermediates and intermediate processes. In one aspect, glycosyl halides are produced by reaction o

Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors

Aminoalkyl glucosaminide phosphate (AGP) compounds that are adjuvants and immunoeffectors are described and claimed. The compounds have a 2-deoxy-2-amino glucose in glycosidic linkage with an aminoalkyl (aglycon) group. Compounds are phosphorylated at the 4 or 6 carbon on the glucosaminide ring and comprise three 3-alkanoyloxyalkanoyl residues. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Compositions and methods for using the compounds as adjuvants and immunoeffectors are also disclosed.

Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors

Aminoalkyl glucosaminide phosphate (AGP) compounds that are adjuvants and immunoeffectors are described and claimed. The compounds have a 2-deoxy-2-amino glucose in glycosidic linkage with an aminoalkyl (aglycon) group. Compounds are phosphorylated at the 4 or 6 carbon on the glucosaminide ring and comprise three 3- alkanoyloxyalkanoyl residues. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Compositions and methods for using the compounds as adjuvants and immunoeffectors are also disclosed.

Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors

Aminoalkyl glucosamine phosphate compounds that are adjuvants and immunoeffectors are described and claimed. The compounds have a 2-deoxy-2-amino glucose in glycosidic linkage with an aminoalkyl (aglycon) group. Compounds are phosphorylated at the 4 or 6 carbon on the glucosamine ring and comprise three 3-alkanoyloxyalkanoyl residues. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Methods for using the compounds as adjuvants and immunoeffectors are also disclosed.

Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors

Aminoalkyl glucosaminide phosphate (AGP) compounds that are adjuvants and immunoeffectors are described and claimed. The compounds have a 2-deoxy-2-amino glucose in glycosidic linkage with an aminoalkyl (aglycon) group. Compounds are phosphorylated at the 4 or 6 carbon on the glucosaminide ring and comprise three 3-alkanoyloxyalkanoyl residues. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Methods for using the compounds as adjuvants and immunoeffectors are also disclosed.

Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors

Aminoalkyl glucosamine phosphate compounds that are adjuvants and immunoeffectors are described and claimed. The compounds have a 2-deoxy-2-amino glucose in glycosidic linkage with an aminoalkyl (aglycon) group. Compounds are phosphorylated at the 4 or 6 carbon on the glucosamine ring and comprise three 3-alkanoyloxyalkanoyl residues. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Methods for using the compounds as adjuvants and immunoeffectors are also disclosed.